NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Members of the specialty earned a median salary of approximately $239,200 last year, based on survey data gathered by the media company last fall.Read More